The selective use of AMSA following high-dose cytarabine in patients with acute myeloid leukaemia in relapse: a Leukemia Intergroup Study-Reference-Cited by-同舟云学术

The selective use of AMSA following high-dose cytarabine in patients with acute myeloid leukaemia in relapse: a Leukemia Intergroup Study

Published:1992-10 Issue:2 Volume:82 Page:337-346
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Larson Richard A.,Day Roger S.,Azarnia Nozar,Bennett John M.,Browman George,Goldberg Jack,Gottlieb Arlan,Grunwald Hans,Miller Kenneth,Raza Azra,Vogler Ralph,Winton Elliot,Preisler Harvey D.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.1992.tb06427.x/fullpdf

Reference21 articles.

1. Proposed Revised Criteria for the Classification of Acute Myeloid Leukemia

2. Amsacrine: A review

3. A.P. Early, H.D. Preisler, D.J. Higby, M. Brecher, G. Browman, and J.A. McBride (1982 ) High-dose cytosine arabinoside: clinical response to therapy in acute leukemia . Medical and Pediatric Oncology, Suppl. 1, 239 -250 .

4. Treatment of patients with acute nonlymphocytic leukemia in relapse: A leukemia intergroup study

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relapsed Acute Myeloid Leukemia: Need for Innovative Treatment Strategies to Improve Outcome;Clinical Lymphoma Myeloma and Leukemia;2015-06

2. New Treatments and Strategies in Acute Myeloid Leukemia;Clinical Lymphoma Myeloma and Leukemia;2011-06

3. An effective age-unrestricted m-AMSA-based second-line regimen for poor prognosis acute myeloid leukaemia;European Journal of Haematology;2009-04-24

4. Current and emerging therapies for acute myeloid leukemia;Clinical Therapeutics;2009-01

5. Timed-sequential chemotherapy as induction and/or consolidation regimen for younger adults with acute myelogenous leukemia;Hematology;2007-02